Summary

Coherent (COHR) reported strong Q2 datacenter growth (34% YoY) but Q3 guidance signals deceleration to +5% QoQ sequential growth (midpoint $1.77B vs Q2 $1.69B). Market sold off -7.9% on Feb 4 while competitor Lumentum (LITE) rallied +7.0% on Feb 3, signaling competitive share loss concerns.

Key tension: Cash flow collapsed 69% YoY despite earnings up 192%. Management frames inventory build (+$421M in 6 months) as intentional capacity positioning ahead of locked-in demand (book-to-bill 4×, customers "placing orders further out in time"). But inventory turns are declining (3.5× current vs 4.7× prior year) and revenue growth is decelerating into Q3, not accelerating. Bull case: Pre-positioning for H2 surge. Bear case: Demand not pulling as fast as production.

Cross-ticker pattern: Competitive divergence. LITE's Q3 guidance projects +85% YoY growth with disclosed OCS backlog >$400M. LITE CEO: "now in the lead pack of transceiver suppliers as customers transition to 1.6T speeds." GLW showed optical +35% YoY with datacenter +61%. VIAV datacenter now 45% of revenue. Market is rotating to LITE while COHR decelerates.

Thesis shift: From "AI datacenter wave lifts all boats" to "LITE taking share from COHR in growing market."

Valuation stretched: 32.8× NTM P/E (blended FY2026/FY2027 consensus) requires sustained >20% growth, but Q3 guidance shows deceleration to +5% QoQ (vs +9% in Q2).

Expected value: -7.6% (slight downside). Not a conviction short, but asymmetric risk/reward favors waiting for Q3 results (May 2026) before entry.

What Happened

Q2 FY2026 (Dec 2025 quarter) - Strong headline numbers:

  • Revenue: $1.69B (+17% YoY, +9% QoQ pro forma)
  • Datacenter & Communications: $1.21B (+34% YoY, +11% QoQ)
  • Non-GAAP gross margin: 39% (+77bps YoY, +24bps QoQ)
  • Non-GAAP EPS: $1.29 (+35% YoY, +11% QoQ)

Management commentary was bullish: "continued strong AI datacenter demand," "elevated demand for new ZR/ZR+ transceivers," "exceptional demand from customers," and "book-to-bill ratio exceeded 4×."

But guidance reveals deceleration:

  • Q3 FY2026 (Mar 2026 quarter): $1.70-1.84B (midpoint $1.77B)
  • Sequential growth: +$80M or +4.7% QoQ (vs +9% in Q2)
  • CEO on earnings call: "expect continued strong sequential revenue growth in both March and June quarters"
  • But math shows: If Q2 was +9% QoQ and Q3 guide is +4.7% QoQ, growth rate is decelerating

Cash flow tension:

  • Operating cash flow: $104M (vs $340M prior year) - down 69% YoY
  • Net earnings: $369M (up 192% YoY) - massive divergence between earnings and cash
  • Inventory build: +$421M in 6 months (vs +$67M prior year) - 6.3× larger build
  • Inventory turns: 3.5× (current) vs 4.7× (prior year) - declining efficiency

Management explanation (Transcript line 30):

"book-to-bill ratio exceeded 4× as customers increasingly place orders further out in time"

Two interpretations:

  1. Bull case: Intentional capacity build ahead of locked-in orders. 4× book-to-bill = confident pre-positioning for H2 2026 surge. Longer lead times reflect locked-in LTA (long-term agreement) commitments, not weak demand.
  2. Bear case: Inventory piling up faster than demand can pull it. Declining inventory turns (3.5× vs 4.7×) + revenue deceleration (Q3 +4.7% vs Q2 +9%) = production outpacing sales. "Orders further out in time" = customers hesitating to take delivery, extending lead times.

Given book-to-bill 4× and disclosed LTA commitments, bull interpretation has stronger support from primary sources. However, the market's -7.9% reaction suggests skepticism about whether this inventory converts to revenue at expected pace.

Competitive divergence - same day, opposite moves:

  • Feb 4, 2026: COHR -7.9% on earnings (volume 2.72× normal)
  • Feb 3, 2026: LITE +7.0% on earnings (volume 2.58× normal)

The LITE Threat

Lumentum reported Q2 FY2026 earnings Feb 3 (one day before COHR) and the contrast is striking:

LITE's Q2 results:

  • Revenue: $666M (+65% YoY, +38% QoQ)
  • Q3 guidance: $780-830M (midpoint $805M, +85% YoY growth)
  • Gross margin: 42.5% (vs COHR 39%)
  • Operating margin: 25.2% (vs COHR 19.9%)
  • OCS backlog: >$400M (mostly shipping H2 CY2026)

Key point: The LITE comparison is guidance-to-guidance (both companies' Q3 forward outlook), not results-to-results. LITE's Q3 guidance shows +85% YoY growth acceleration, while COHR's Q3 guidance shows sequential deceleration (+4.7% QoQ vs +9% prior quarter).

LITE CEO Michael Hurlston (Q2 call):

"We are now in the lead pack of transceiver suppliers as customers transition their networks to 1.6T speeds. Beyond design execution, we are also improving the profitability of our transceiver business, with better yields and lower scrap rates."

"Cloud transceivers accounted for the lion's share of this growth, increasing by approximately $50 million on the quarter. As we begin to see the revenue layering benefits typically enjoyed by larger transceiver makers."

"We achieved another record quarter for our pump lasers... with revenue in this product line surging over 90% compared to the prior year."

Key differentiation:

  1. Design execution: LITE "greatly improved execution through the design cycle" and is "now in the lead pack" for 1.6T
  2. Time to market: LITE explicitly called out speed to market as competitive advantage
  3. Profitability: LITE gross margin 42.5% vs COHR 39%, and LITE improving "better yields and lower scrap rates"
  4. Momentum: LITE sequential growth +38% vs COHR +9% (and guiding +85% YoY vs COHR's implied ~+17% YoY)

Cross-Ticker Pattern: Sector Strong, But Share Shifting

The optical networking sector is booming:

  1. GLW (Corning): Optical Communications +35% YoY (FY2025), datacenter +61% YoY, $6B Meta deal
  2. VIAV: Datacenter now 45% of revenue (up from single digits one year ago), Q2 field instruments from datacenters 33%
  3. LITE: Q3 guidance +85% YoY, OCS backlog >$400M, "lead pack" in 1.6T transceivers
  4. COHR: +34% YoY in Q2, but decelerating to +4.7% QoQ in Q3

This is NOT "sector weakness" - this is competitive divergence.

Market interpretation: LITE winning share, COHR losing momentum in a growing market.

Insider Transactions: All Sells, No Buys

Form 4 filings Nov-Dec 2025 (pre-earnings):

November sales:

  • Nov 25: Executive VP sold at $174
  • Nov 21: EVP sold at $176
  • Nov 17: Director sold at $180
  • Nov 14: Director sold 11,570 shares at $145 avg ($1.68M)
  • Nov 12: CFO Sherri Luther sold at $197

December sales:

  • Dec 10: Director sold 15,000 shares at $197 avg ($2.95M)
  • Dec 3: Director sold at $165
  • Dec 2: Director sold at $170 (and converted options)
  • Dec 1: Officer sold at $163

Zero insider buys in past 6 months.

Stock now at $211. Insiders were selling at $145-197 range (+6% to +45% below current price).

Critical detail: SEC Form 4 filings show NO disclosure of 10b5-1 trading plans (pre-scheduled automatic sales). This means the Nov-Dec sales appear to be discretionary, not pre-programmed. Discretionary insider selling ahead of guidance deceleration is a bearish signal.

Context on magnitude: The Dec 10 sale of 15,000 shares ($2.95M) by Director Corasanti and Nov 14 sale of 11,570 shares ($1.68M) by Director Dreyer represent significant dollar amounts. Without knowing total holdings, it's unclear what % of their positions were sold, but the absolute dollar values indicate material liquidation events.

Valuation: Priced for Perfection

Current price: $211 Forward P/E: 32.8× (based on NTM blended consensus EPS ≈$6.43)

Clarification on "forward P/E":

  • FY2026 consensus EPS: $5.10 (fiscal year ends June 2026, 4 months away)
  • FY2027 consensus EPS: $6.36 (fiscal year ends June 2027)
  • NTM (next-12-month) blended: ≈$6.43 (mixing Q3-Q4 FY2026 + Q1-Q2 FY2027)
  • P/E calculation: $211 / $6.43 = 32.8×

What's priced in:

  • Sustained 20-25% revenue growth
  • Continued margin expansion
  • Market share gains in transceivers
  • OCS revenue ramp (COHR has OCS product but no disclosed backlog like LITE's >$400M)

What's happening:

  • Revenue growth decelerating (Q2 +9% QoQ → Q3 guide +4.7% QoQ)
  • Cash flow negative divergence from earnings (intentional inventory build per mgmt)
  • Competitor LITE taking share in 1.6T transceivers (guidance momentum diverging)
  • Inventory efficiency declining (3.5× turns vs 4.7× prior year)

Fair value scenarios:

  1. Bull case (25% probability): Inventory build converts to revenue in H2 2026, Q3 comes in at high end of guide ($1.84B), Q4 accelerates back to +10% QoQ, COHR wins 1.6T share alongside LITE

    • Fair value: $250 (maintains premium 35-38× P/E for sustained 20%+ growth)
    • Upside from $211: +$39 (+18%)

  2. Base case (50% probability): Growth stabilizes at 10-15% YoY, margins stay flat, COHR and LITE both grow but LITE faster, cash flow recovers as inventory normalizes

    • Fair value: $190 (valuation compresses to 27-30× P/E on slower growth)
    • Downside from $211: -$21 (-10%)

  3. Bear case (25% probability): Inventory write-downs, margin compression from competitive pricing pressure to match LITE, cash flow stays negative, LITE takes significant share, Q3 misses low end of guide

    • Fair value: $150 (valuation compresses to 22-25× P/E on sustained deceleration)
    • Downside from $211: -$61 (-29%)

Expected value calculation:

  • Bull: 25% × (+$39) = +$9.75
  • Base: 50% × (-$21) = -$10.50
  • Bear: 25% × (-$61) = -$15.25
  • Total EV: -$16 or -7.6% from current $211

Risk/reward assessment: Stock up +134% in past year, valuation stretched at 32.8× NTM P/E, growth decelerating into Q3, competitor accelerating. Asymmetric downside: +18% upside (bull case) vs -29% downside (bear case). Base case alone is -10%.

What to Watch

Catalyst timeline:

  1. Q3 FY2026 earnings (May 2026):

    • Does revenue come in at high end of guide ($1.84B) or low end ($1.70B)?
    • Does cash flow recover (inventory converts to sales) or stay compressed?
    • Does management guide Q4 with acceleration or continued deceleration?
    • Does gross margin hold at 39% or compress (competitive pricing pressure)?

  2. LITE's March quarter results (May 2026):

    • If LITE prints $805M revenue (+85% YoY) and COHR prints $1.77B (+17% YoY), divergence widens
    • LITE OCS backlog conversion: Are they shipping $100M+ per quarter in OCS while COHR stays silent?
    • Does LITE maintain or expand gross margin lead (42.5% vs COHR 39%)?

  3. Insider transactions:

    • Any insider buying at current levels ($211) would be bullish signal (validation after deceleration)
    • Continued discretionary selling would confirm deceleration concerns (insiders exiting ahead of results)

Key questions:

  • Is COHR losing 1.6T transceiver share to LITE? (guidance momentum divergence suggests yes)
  • Why is inventory building faster than revenue? (mgmt says intentional, market skeptical)
  • When does operating cash flow recover? (Q3 will be critical test of thesis)
  • What is COHR's OCS backlog? (LITE disclosed >$400M, COHR silent - competitive disadvantage in disclosure?)

Investment Implication

Slight bearish lean (not conviction short). Market repriced COHR down 7.9% on Feb 4 while LITE rallied 7.0% on Feb 3, signaling competitive share loss concerns are real and being priced. Expected value is -7.6%, indicating modest downside but not extreme.

Recommendation: WAIT for Q3 results (May 2026) before taking long position.

Current entry at $211 has:

  • Limited upside: +18% to $250 (bull case, requires reacceleration)
  • Significant downside: -29% to $150 (bear case, if deceleration persists)
  • Base case already negative: -10% to $190 (50% probability scenario)

NOT a strong short candidate unless:

  • Q3 revenue misses low end of guide (<$1.70B)
  • LITE prints >$805M and sustains 70%+ YoY growth (competitive divergence widens)
  • Operating cash flow stays below $150M in Q3 (inventory not converting)
  • Inventory write-downs or gross margin compression announced
  • Insider selling continues through Q3

Why not stronger bearish signal:

  • Book-to-bill 4× and LTA commitments support bull case (intentional capacity build)
  • Sector growth is real (GLW, VIAV, LITE all strong) - not macro weakness
  • COHR still growing 34% YoY in datacenter (just decelerating, not declining)
  • Management has track record of beating guidance (last 4 quarters all beats)

Risk/reward tilts bearish, but magnitude is modest (-7.6% EV). Better to wait for Q3 data point than to short into uncertainty. If Q3 confirms deceleration, setup improves materially for short entry.

Source Analysis

10-Q filing (Feb 4, 2026): Primary source for financials, inventory build +$421M, cash flow down 69% YoY, inventory turns 3.5× vs 4.7×

Earnings call transcript (Feb 4, 2026): Management commentary on demand, "book-to-bill ratio exceeded 4×," "customers placing orders further out in time," guidance $1.70-1.84B

LITE earnings call (Feb 3, 2026): Competitive positioning, "lead pack" in 1.6T transceivers, Q3 guidance +85% YoY, OCS backlog >$400M disclosed

Form 4 filings (Nov-Dec 2025): Discretionary insider selling at $145-197 range (no 10b5-1 plan disclosures), zero insider buys in 6 months

Worldview evidence: GLW optical +35% YoY, VIAV datacenter 45% of revenue, cross-ticker sector strength validates datacenter demand, but COHR losing relative momentum

yfinance market data: COHR -7.9% on Feb 4 (volume 2.7× normal), forward P/E 32.8×, consensus targets mean $203 (median $210), range $113-265

Confidence: High (85/100)

  • Primary sources confirm all numbers (10-Q, transcripts, Form 4s)
  • Cross-ticker competitive pattern clear (LITE guidance accelerating, COHR decelerating)
  • Cash flow divergence from earnings is red flag, but management explanation (intentional inventory build) has support from 4× book-to-bill
  • Discretionary insider selling pre-earnings (no 10b5-1 plans disclosed) is red flag
  • Inventory turn decline + guidance deceleration = demand may not be as strong as management claims, OR capacity build ahead of surge (data point in Q3 will resolve)